Jan Langeveld

9.0k citations
153 papers · 6.6k indexed · h-index 46

Jan Langeveld

151 papers receiving 6.3k citations

Peers

Jan Langeveld
Comparison fields: 5 of 120
  • Neurology 1.9k
  • Immunology and Allergy 746
  • Nutrition and Dietetics 1.4k
  • Molecular Biology 4.6k
  • Biotechnology 465
Replace Hisashi Arase with:
Hisashi Arase Japan
Andreas Zurbriggen Switzerland
Heidrun Kirschke Germany
Kayo Inaba Japan
Hisayuki Nomiyama Japan
Karsten Mahnke Germany
Ralf F. Pettersson Sweden
Robert R. Friis Germany
Ted H. Hansen United States
Jan Langeveld relative to Hisashi Arase Japan Hisashi Arase's profile →
Citations per field
00.5×8.6×
Hisashi Arase · 1×
Citations per year

Countries citing papers authored by Jan Langeveld

Since Specialization
Citations

This map shows the geographic impact of Jan Langeveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Langeveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Langeveld more than expected).

Fields of papers citing papers by Jan Langeveld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Langeveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Langeveld. The network helps show where Jan Langeveld may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jan Langeveld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Langeveld Line = papers co-authored together Jan Langeveld links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 201331
3 201317
4 201382
5 20127
6 20112
7 2009185
8 200943
9 200697
10 20063
11 200311
12 200245
13 200083
14 199929
15 199851
16 199737
17
Success with a peptide vaccine in the target animal: firm protection against viral host-range variants
19961
18 199338
19 199125
20 19901

About Jan Langeveld

Jan Langeveld is a scholar working on Neurology, Nutrition and Dietetics and Immunology and Allergy, having authored 153 papers that have together received 6.6k indexed citations. Recurring topics across this work include Prion Diseases and Protein Misfolding (94 papers), Neurological diseases and metabolism (56 papers), Trace Elements in Health (40 papers), Animal Virus Infections Studies (17 papers), Virus-based gene therapy research (16 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Metallurgy and Material Science (10 papers) and Cell Adhesion Molecules Research (10 papers). The work is most often cited by research in Neurology (1.9k citations), Immunology and Allergy (746 citations) and Nutrition and Dietetics (1.4k citations). Jan Langeveld has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Lucien van Keulen, Rob H. Meloen, Billy G. Hudson, B. E. C. Schreuder, M. E. W. Vromans, Jörgen Wieslander, J. Ignacio Casal, M.A. Smits, Carmen Vela and F.G. van Zijderveld. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026